MoonLake Immunotherapeutics (MLTX) had the highest return between January 30, 2023 and March 1, 2023 by a mid-cap US stock, returning 66.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
MoonLake Immunotherapeutics (MLTX) | 1/30/2023 - 3/1/2023 | 66.94% |
Ocular Therapeutix (OCUL) | 1/30/2023 - 3/1/2023 | 56.85% |
SoundHound AI (SOUN) | 1/30/2023 - 3/1/2023 | 53.26% |
Oscar Health (OSCR) | 1/30/2023 - 3/1/2023 | 51.64% |
VEON (VEON) | 1/30/2023 - 3/1/2023 | 47.27% |
Intapp (INTA) | 1/30/2023 - 3/1/2023 | 37.26% |
International Seaways (INSW) | 1/30/2023 - 3/1/2023 | 36.03% |
Frontline (FRO) | 1/30/2023 - 3/1/2023 | 34.2% |
Viking Therapeutics (VKTX) | 1/30/2023 - 3/1/2023 | 32.91% |
IREN (IREN) | 1/30/2023 - 3/1/2023 | 32.37% |
Merus (MRUS) | 1/30/2023 - 3/1/2023 | 32.2% |
Goosehead Insurance (GSHD) | 1/30/2023 - 3/1/2023 | 31.27% |
Lantheus (LNTH) | 1/30/2023 - 3/1/2023 | 30.94% |
ELF Beauty (ELF) | 1/30/2023 - 3/1/2023 | 30.73% |
ZIM Integrated Shipping Services (ZIM) | 1/30/2023 - 3/1/2023 | 29.95% |
Scorpio Tankers (STNG) | 1/30/2023 - 3/1/2023 | 28.1% |
Materion (MTRN) | 1/30/2023 - 3/1/2023 | 27.67% |
Nextdecade (NEXT) | 1/30/2023 - 3/1/2023 | 27.64% |
Scotts Miracle-Gro (SMG) | 1/30/2023 - 3/1/2023 | 27.44% |
BridgeBio Pharma (BBIO) | 1/30/2023 - 3/1/2023 | 25.72% |
MYR (MYRG) | 1/30/2023 - 3/1/2023 | 25.65% |
Allegro Microsystems (ALGM) | 1/30/2023 - 3/1/2023 | 25.24% |
Miniso Group Holding (MNSO) | 1/30/2023 - 3/1/2023 | 24.01% |
Appfolio (APPF) | 1/30/2023 - 3/1/2023 | 23.73% |
Weatherford International (WFRD) | 1/30/2023 - 3/1/2023 | 23.58% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
